A new study demonstrating the conversion of oral cannabidiol (CBD) to the psychoactive component tetrahydrocannabinol (THC) in the presence of gastric fluids could explain why children given CBD to treat epilepsy had an unexpectedly high rate of adverse effects such as sleepiness and fatigue. The study, “Identification of Psychoactive Degradants of Cannabidiol in Simulated Gastric […]
However, what most people do not know is that the Cannabis Australia is allowing to be imported for the first time includes GMO Cannabis. GMO or Genetically Modified Organism Cannabis has been around since 2011 due to breakthroughs in research and Biotechnology by Ethan Russo and GW UK helping in the process. In 2014 even
Australia legislates for 100% GMO Biotech Cannabis not Marijuana Read More »
Epilepsy sufferer, 13, who became poster child for medical marijuana after moving to Maine to access alternative treatment has died in her father’s arms Cyndimae Meehan, 13, sparked media attention and changed policy. She moved to Maine from Connecticut as FDA drugs had failed her. Only cannabis oil effectively treated her habitual seizures, family claimed.
Poster child for medical marijuana dies Read More »
Nicole MacKee – Monday, 30 May, 2016 THE importance of building a solid evidence base for the role of medicinal cannabis products must not be lost in moves to make the drug more widely available, say researchers. In a Perspective published online by the MJA today, researchers have called for “considered management” in the wake of
Slow and steady on medicinal cannabis Read More »
Published: Thursday 5 May 2016 According to new research at Western University, marijuana is the ultimate contradiction; at least when it comes to schizophrenia. This first-of-its-kind study, published in the journal Neuroscience, demonstrates that a chemical found in marijuana called cannabidiol, or CBD, affects the brain in a way that makes it an ideal treatment
Chemical in marijuana shows promise in treating schizophrenia Read More »
By Bertha Madras April 29 2016 Each week, In Theory takes on a big idea in the news and explores it from a range of perspectives. This week, we’re talking about drug scheduling. Need a primer? Catch up here. Bertha Madras is a professor of psychobiology at McLean Hospital and Harvard Medical School, with a research
5 reasons marijuana is not medicine Read More »
Scott E. Hadland, MD, MPH,1,2 John R. Knight, MD,1,3 and Sion K. Harris, PhD1,2,3Author information ► Copyright and License information ►The publisher’s final edited version of this article is available at J Dev Behav PediatrSee other articles in PMC that cite the published article. AbstractMarijuana policy is rapidly evolving in the United States and elsewhere, with
Wilkinson ST1, Stefanovics E, Rosenheck RA. Abstract OBJECTIVE:An increasing number of states have approved posttraumatic stress disorder (PTSD) as a qualifying condition for medical marijuana, although little evidence exists evaluating the effect of marijuana use in PTSD. We examined the association between marijuana use and PTSD symptom severity in a longitudinal, observational study.METHOD:From 1992 to
• Katherine A Belendiuk,• Lisa L Baldini and• Marcel O Bonn-MillerEmail authorAddiction Science & Clinical Practice201510:10 DOI: 10.1186/s13722-015-0032-7 © Belendiuk et al.; licensee BioMed Central. 2015 Published: 21 April 2015 AbstractThe present investigation aimed to provide an objective narrative review of the existing literature pertaining to the benefits and harms of marijuana use for the treatment
